DCI Center for Prostate & Urologic Cancers (@dukegucancer) 's Twitter Profile
DCI Center for Prostate & Urologic Cancers

@dukegucancer

A multidisciplinary center within @DukeCancer focused on patient care and cutting-edge clinical, translational and population research.

ID: 1001806953474150400

linkhttps://prostateurologiccenter.dukecancerinstitute.org calendar_today30-05-2018 12:46:05

1,1K Tweet

1,1K Followers

210 Following

Tian Zhang, MD, MHS (@tiansterzhang) 's Twitter Profile Photo

Today was a bittersweet day as I held my last clinic session Duke Department of Medicine Duke Cancer. 12 yrs here - these are the halls where I gained my clinical acumen, grew into an oncologist, and developed some research skills. I am so sad and so grateful for every minute of these 12 yrs.

Today was a bittersweet day as I held my last clinic session <a href="/dukemedicine/">Duke Department of Medicine</a> <a href="/DukeCancer/">Duke Cancer</a>. 12 yrs here - these are the halls where I gained my clinical acumen, grew into an oncologist, and developed some research skills. I am so sad and so grateful for every minute of these 12 yrs.
Andrew Armstrong (@aarmstrongduke) 's Twitter Profile Photo

Thrilled to share our latest ARCHES analysis by risk/volume/prior therapy to provide valuable information to men with mHSPC. Great teamwork with Arun Azad DCI Center for Prostate & Urologic Cancers Astellas Pharma US Pfizer Inc. urldefense.com/v3/__https://r…$

OncLive SOSS (@onclivesoss) 's Twitter Profile Photo

.Tian Zhang, MD, MHS, of Duke Cancer, discussed key considerations regarding frontline immunotherapy-based combinations in RCC and recent data from pivotal trials examining their use #kcsm ow.ly/Wy4Q50FVaup

.<a href="/TiansterZhang/">Tian Zhang, MD, MHS</a>, of <a href="/DukeCancer/">Duke Cancer</a>, discussed key considerations regarding frontline immunotherapy-based combinations in RCC and recent data from pivotal trials examining their use #kcsm ow.ly/Wy4Q50FVaup
Judd Moul (@juddmoul) 's Twitter Profile Photo

One week to go until #AUA21. Looking forward to debate with Li-Ming Su, M.D. on pros and cons of maintaining open RRP experience for urology residency training. Friday September 10th live during plenary session. Duke Urology Duke Cancer DCI Center for Prostate & Urologic Cancers

One week to go until #AUA21. Looking forward to debate with <a href="/LiMingSu1/">Li-Ming Su, M.D.</a> on pros and cons of maintaining open RRP experience for urology residency training.  Friday September 10th live during plenary session.  <a href="/DukeUrology/">Duke Urology</a> <a href="/DukeCancer/">Duke Cancer</a> <a href="/DukeGUCancer/">DCI Center for Prostate & Urologic Cancers</a>
Checkpoint Now Podcast Series (@checkpointnowmd) 's Twitter Profile Photo

We are back after a break. This time with an episode showcasing resident perspective on managing irAEs. Join hosts Afreen Shariff, MD Tian Zhang, MD, MHS as they d/w Duke IM Residency physicians @nathanhirshy Michelle Ferreira Dr. Harsh Patolia to learn more. 👉 checkpointnow.org

Andrew Armstrong (@aarmstrongduke) 's Twitter Profile Photo

Join us for spring break at Disney! The Duke Urologic Assembly 2022 is on! Both in person and hybrid options are available with a great team of expert speakers for this CME event focused on precision urologic oncology and urology: DCI Center for Prostate & Urologic Cancers mailchi.mp/7bf30a6ae09a/a…

Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

Register now for the DCI Center for Prostate & Urologic Cancers patient education symposium on GU cancers on Friday. Watch for the #kidneycancer session featuring Dan George William Y. Kim and Dr. Stacey Lisi. supportdukehealth.org/site/TR?fr_id=…

Register now for the <a href="/DukeGUCancer/">DCI Center for Prostate & Urologic Cancers</a> patient education symposium on GU cancers on Friday. Watch for the #kidneycancer session featuring <a href="/Daniel_J_George/">Dan George</a> <a href="/WilliamKimMD/">William Y. Kim</a> and Dr. Stacey Lisi. supportdukehealth.org/site/TR?fr_id=…
The PCCTC (@thepcctc) 's Twitter Profile Photo

Study by esteemed PCCTC investigator Dan George (DCI Center for Prostate & Urologic Cancers) and colleagues finds black men with chemotherapy-naïve metastatic prostate cancer initiating novel hormonal therapy may have better outcomes than similarly treated white men nature.com/articles/s4139…

Study by esteemed PCCTC investigator <a href="/Daniel_J_George/">Dan George</a> (<a href="/DukeGUCancer/">DCI Center for Prostate & Urologic Cancers</a>) and colleagues  finds black men with chemotherapy-naïve metastatic prostate cancer initiating novel hormonal therapy may have better outcomes than similarly treated white men nature.com/articles/s4139…
DCI Center for Prostate & Urologic Cancers (@dukegucancer) 's Twitter Profile Photo

1 in 8 men will be diagnosed with #prostatecancer in their lifetime. If caught early, most can be cured. Men over 50, talk to your doc ab #prostate #cancer #screening – a simple blood test could save your life. Duke Cancer

Duke Clinical and Translational Science Institute (@duke_ctsi) 's Twitter Profile Photo

We proudly present our 2022 impact report, highlighting valuable contributions to advancing science, research, and health equity and the great work we have achieved with our partners. CTSI Translational Impact: Advancing Equity Read the report ➡️ sites.duke.edu/ctsiimpact2022/

We proudly present our 2022 impact report, highlighting valuable contributions to advancing science, research, and health equity and the great work we have achieved with our partners.

CTSI Translational Impact: Advancing Equity

Read the report ➡️ sites.duke.edu/ctsiimpact2022/